191 related articles for article (PubMed ID: 11872915)
41. Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin: results of the TOPAS trial. Therapy of Patients With Acute Stroke (TOPAS) Investigators.
Diener HC; Ringelstein EB; von Kummer R; Langohr HD; Bewermeyer H; Landgraf H; Hennerici M; Welzel D; Gräve M; Brom J; Weidinger G
Stroke; 2001 Jan; 32(1):22-9. PubMed ID: 11136909
[TBL] [Abstract][Full Text] [Related]
42. Intravenous heparin for acute stroke: what can we learn from the megatrials?
Estol CJ
Neurology; 2000 Apr; 54(7):1542-3. PubMed ID: 10751280
[No Abstract] [Full Text] [Related]
43. Antithrombotic and hypofibrinogenetic therapy in acute ischemic stroke: what is the next step?
Sherman DG
Cerebrovasc Dis; 2004; 17 Suppl 1():138-43. PubMed ID: 14694291
[TBL] [Abstract][Full Text] [Related]
44. Antithrombotic Therapy Strategy for Cancer-Associated Ischemic Stroke: A Case Series of 26 Patients.
Naito H; Nezu T; Hosomi N; Aoki S; Ueno H; Ochi K; Maruyama H
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):e206-e211. PubMed ID: 29779882
[TBL] [Abstract][Full Text] [Related]
45. Direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: focus on real life studies.
Masotti L; Grifoni E; Dei A; Vannucchi V; Moroni F; Panigada G; Spolveri S; Landini G
J Thromb Thrombolysis; 2019 Feb; 47(2):292-300. PubMed ID: 30470967
[TBL] [Abstract][Full Text] [Related]
46. Heparin in acute ischemic stroke revisited.
Chamorro A
Rev Neurol (Paris); 2008 Oct; 164(10):815-8. PubMed ID: 18778842
[TBL] [Abstract][Full Text] [Related]
47. To Treat or Not to Treat: Anticoagulants as Secondary Preventives to the Oldest Old With Atrial Fibrillation.
Appelros P; Farahmand B; Terént A; Åsberg S
Stroke; 2017 Jun; 48(6):1617-1623. PubMed ID: 28487335
[TBL] [Abstract][Full Text] [Related]
48. Increased risk of hemorrhagic transformation in ischemic stroke occurring during warfarin anticoagulation: an experimental study in mice.
Pfeilschifter W; Spitzer D; Czech-Zechmeister B; Steinmetz H; Foerch C
Stroke; 2011 Apr; 42(4):1116-21. PubMed ID: 21330626
[TBL] [Abstract][Full Text] [Related]
49. Anticoagulants versus antiplatelet agents for acute ischemic stroke.
Hankey GJ; Berge E; Sandercock P
Stroke; 2003 Jun; 34(6):1571-2. PubMed ID: 12764231
[No Abstract] [Full Text] [Related]
50. Standard medical management in secondary prevention of ischemic stroke in China (SMART).
Peng B; Zhu Y; Cui L; Ni J; Xu W; Zhou L; Yao M; Chen L; Wang J; Wang Y; Pu C;
Int J Stroke; 2011 Oct; 6(5):461-5. PubMed ID: 21951412
[TBL] [Abstract][Full Text] [Related]
51. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
[TBL] [Abstract][Full Text] [Related]
52. Cerebral Microbleeds and the Safety of Anticoagulation in Ischemic Stroke Patients: A Systematic Review and Meta-Analysis.
Liang Y; Song Q; Jiao Y; Lin J; Qu H; Zhao S; Xu J; Zhao C; Zhao M
Clin Neuropharmacol; 2018; 41(6):202-209. PubMed ID: 30418264
[TBL] [Abstract][Full Text] [Related]
53. Timing of anticoagulation therapy in patients with acute ischaemic stroke and atrial fibrillation.
Paciaroni M; Agnelli G; Ageno W; Caso V
Thromb Haemost; 2016 Aug; 116(3):410-6. PubMed ID: 27346426
[TBL] [Abstract][Full Text] [Related]
54. The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.
Keskar V; McArthur E; Wald R; Harel Z; Zimmerman D; Molnar AO; Garg AX; Lam NN; McCallum MK; Bota SE; Perl J; Sood MM
Kidney Int; 2017 Apr; 91(4):928-936. PubMed ID: 28017326
[TBL] [Abstract][Full Text] [Related]
55. Use of secondary medical prophylaxis and clinical outcome among patients with ischemic stroke: a nationwide follow-up study.
Palnum KH; Mehnert F; Andersen G; Ingeman A; Krog BR; Bartels PD; Johnsen SP
Stroke; 2012 Mar; 43(3):802-7. PubMed ID: 22207506
[TBL] [Abstract][Full Text] [Related]
56. Ischemic and hemorrhagic stroke in patients on oral anticoagulants after reconstruction for chronic lower limb ischemia.
Dawson I; van Bockel JH; Ferrari MD; van der Meer FJ; Brand R; Terpstra JL
Stroke; 1993 Nov; 24(11):1655-63. PubMed ID: 8236338
[TBL] [Abstract][Full Text] [Related]
57. Anticoagulants for acute ischaemic stroke.
Gubitz G; Counsell C; Sandercock P; Signorini D
Cochrane Database Syst Rev; 2000; (2):CD000024. PubMed ID: 10796283
[TBL] [Abstract][Full Text] [Related]
58. Early and late mortality of spontaneous hemorrhagic transformation of ischemic stroke.
D'Amelio M; Terruso V; Famoso G; Di Benedetto N; Realmuto S; Valentino F; Ragonese P; Savettieri G; Aridon P
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):649-54. PubMed ID: 23834850
[TBL] [Abstract][Full Text] [Related]
59. Anticoagulant and defibrinogenating agents in acute ischemic stroke and cerebral venous thrombosis.
Meschia JF
Semin Neurol; 1998; 18(4):461-70. PubMed ID: 9932617
[TBL] [Abstract][Full Text] [Related]
60. How baseline severity affects efficacy and safety outcomes in acute ischemic stroke intervention trials.
Gorelick PB
Ann N Y Acad Sci; 2012 Sep; 1268():85-94. PubMed ID: 22994226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
